HomeAI · summaries
Storia in 2 fonti
Optum Rx, FTC posed for settlement in insulin pricing case
The Federal Trade Commission may be winding down its ongoing insulin case against the three largest pharmacy benefit managers, as court documents suggest the agency has reached an agreement with Op | The Federal Trade Commission may be winding down its ongoing insulin case against the three largest pharmacy benefit managers, as court docs suggest the agency has reached an agreement with Optum Rx.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercehealthcare.com
PSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models
Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any price, a new
- ·
markets.businessinsider.com
UnitedHealth, FTC reach tentative settlement pact over insulin prices
UnitedHealth (UNH) Group subsidiaries OptumRx and Emisar Pharma Services and the Federal Trade Commission have reached an agreement that would s...
